A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia

Acta Psychiatrica Scandinavica

Volumn 110, Issue 1, 2004, Pages 21-28

  Bechdolf, A ^a   Knost, B ^a   Kuntermann, C ^a   Schiller, S ^a   Klosterkotter J ^a   Hambrecht, M ^a   Pukrop, R ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cognitive behaviour therapy; Psychosocial intervention; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; RANDOMIZATION; RECURRENCE RISK; SCHIZOPHRENIA;

ADOLESCENT; ADULT; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PSYCHOTHERAPY, GROUP; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 3042520639     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00300.x     Document Type: Article

References (33)

1. DRURY V, BIRCHWOOD M, COCHRANE R et al. Cognitive therapy and recovery from acute psychosis: a controlled trial. I: Impact on psychotic symptoms. Br J Psychiatry 1996;169:593-601.
2. DRURY V, BIRCHWOOD M, COCHRANE R. Cognitive therapy and recovery from acute psychosis: a controlled trial. III: Five-year follow-up. Br J Psychiatry 2000;177:8-14.
3. HADDOCK G, TARRIER N, MORRISON AP et al. A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis. Soc Psychiatry Psychiatr Epidemiol 1999;34:254-258.
4. KUIPERS E, GARETY P, FOWLER D et al. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of the treatment phase. Br J Psychiatry 1997;171:319-327.
5. KUIPERS E, FOWLER D, GARETY P et al. London-East Anglia randomized controlled trial of cognitive-behavioural therapy for psychosis, III: Follow up and economic evaluation at 18 months. Br J Psychiatry 1998;173:61-68.
6. LEWIS S, TARRIER N, HADDOCK G et al. Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. Br J Psychiatry 2002;181(suppl. 43):91-97.
7. SENSKY T, TURKINGTON D, KINGDON D et al. A randomized controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165-172.
8. TARRIER N, YUSUPOFF L, KINNEY C et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. Br Med J 1998;317:303-307.
9. TARRIER N, WITTKOWSKI A, KINNEY C et al. Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up. Br J Psychiatry 1999;174:500-504.
10. TARRIER N, KINNEY C, MCCARTHY E et al. Two-year follow-up of cognitive-behavioural therapy and supportive counseling in the treatment of persistent symptoms in chronic schizophrenia. J Consult Clin Psychol 2000;5:917-922.
11. GARETY PA, FOWLER D, KUIPERS E. Cognitive-behavioural therapy for medication-resistant symptoms. Schizophr Bull 2000;26:73-86.
12. STANT AD, TENVERGENT EM, GROEN H et al. Cost-effectiveness of the HIT programme in patients with schizophrenia and persistent hallucinations. Acta Psychiatr Scand 2003;107:361-368.
13. TURKINGTON D, KINGDON D, TURNER T et al. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002;180:523-527.
14. WYKES T, PARR AM, LANDLAU S. Group treatment of auditory hallucinations. Exploratory study of effectiveness. Br J Psychiatry 1999;175:180-185.
15. MERINDER LB. Patient education in schizophrenia: a review. Acta Psychiatr Scand 2000;102:98-106.
16. BÄUML J, PITSCHEL-WALZ G, KISSLING W. Psychoedukative Gruppen bei schizophrenen Patienten und Angehörigen. In: STARK A, ed. Verhaltenstherapeutische Ansätze im Umgang mit schizophren Erkrankten. Tübingen: Deutsche Gesellschaft für Verhaltenstherapie, 1995:217-255.
17. RAZALI MS, YAHA H. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 1995;91:331-335.
18. OWENS DGC, CARROLL A, FATTAH S, CLYDE Z, COFFEY I, JOHNSTONE EC. A randomized, controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatr Scand 2001;103:362-369.
19. PUKROP R, MÖLLER HJ, STEINMEYER EM. Quality of life in psychiatry. A systematic contribution to construct validation and the development of the integrative assessment tool 'modular system of quality of life'. Eur Arch Psychiatry Clin Neurosci 2000;250:120-132
20. JANKE W, ERDMAN G, KALLUS W. Stress coping questionnaire. Gottingen, Germany: Hogrefe, 1985.
21. KRAMPEN K. Locus of control questionnaire. Goettingen, Germany: Hogrefe, 1991.
22. KAY SR. The Positive and Negative Syndrome Scale (PANSS) of schizophrenia. Schizophr Bull 1987;13:261-276.
23. JACOBSON NS, REVENSTORF D. Statistics for assessing the clinical significance of psychotherapy techniques: issues, problems, and new developments. Behav Assess 10:133-145.
24. KEMP R, KIROV G, EVERITT B, HAYWARD P, DAVID A. Randomised controlled trial of compliance therapy. Br J Psychiatry 1998;172:413-419.
25. VENTURA J, NUECHTERLEIN KH, LUKOFF D et al. A prospective study of stressful life events and schizophrenic relapse. J Abnorm Psychol 1989;4:407-411.
26. BUCHKREMER G, KLINGBERG S, HOLLE R et al. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care givers. Results of a 2-year follow-up. Acta Psychiatr Scand 1997;96:483-491.
27. ATKINS M, BURGESS A, BOTTOMLEY C, RICCIO M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull 1997;21:224-226.
28. TARRIER N, KINNEY C, MCCARTHY E et al. Coping Strategy Enhancement (CSE): a method of treating residual schizophrenic symptoms. Behav Psychoth 1990;18:283-293.
29. TARRIER N, BECKETT R, HARWOOD S et al. A trial of two cognitive-behavioural methods treating drug-resistant residual psychotic symptoms in schizophrenic patients. I Outcome Br J Psychiatry 1993;162:524-532.
30. BARROWCLOUGH C, HADDOCK G, TARRIER N et al. Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001;158:1706-1713.
31. HORNUNG WP, KIESERG A, FELDMANN R. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns 1996;29:257-268.
32. HORNUNG WP, FELDMANN R, KUNGBERG S, BUCHKREMER G, REKER T. Long-term effects of psychoeducational psychotherapeutic intervention for schizophrenic outpatients and their key-persons - results of a five-year follow-up. Eur Arch Psychiatry Clin Neurosci 1999;29:162-167.
33. JACOBSON NS, ROBERTS LJ, BERNS SB, MCGLINCHEY JB. Methods for defining the clinical significance of treatment effects: description, application, and alternatives. J Consult Clin Psychol 1999;67:300-307.